Upcoming Webinars

Accelerating Vaccine Development through Use of Blood-Free Components

This GEN webinar, sponsored by Invitria, will discuss the real contamination risks described in a recent study and how companies are rising to this challenge through a better selection of components and excipients.

Scalable AAV Manufacturing: Addressing Challenges Across the Workflow

In this GEN webinar, sponsored by Thermo Fisher Scientific, our presenters will highlight upstream and downstream solutions across the AAV production workflows.

High-Throughput Proteomics During a Pandemic

In this GEN webinar, sponsored by Bruker, our esteemed presenter Dr. Roman Fischer from the University of Oxford, will showcase the application andlimitations of high-throughput timsTOF Pro mass spectrometry on large scale clinicalsample sets in order to stratify patients and contribute to a multi-omics blood atlasof COVID-19 patients, and the combination of laser capture microdissection withproteomics methods for the 3D characterization of large biological macrostructuressuch as organs or tumors.

Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

In this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.

AAV Based Gene Therapy for Rare Genetic Disorders: Strategies and Challenges

In this GEN webinar, sponsored by WuXi AppTec, we will review the challenges of utilizing AAV, as well as discuss in detail the recent progress and outstanding questions in AAV-based gene therapy.

On Demand Webinars

The Future of Genomics

In Episode 7 of GEN Live, the last of 2020, we looked ahead into 2021 and beyond. Two experts in genomics from the NHGRI, and authors of the strategic plan, discussed their process, how they chose a focus, and how their vision could be implemented. More broadly, we discussed the ups and downs in the history of the field of genomics and where it is going.

Confidence in Clinical Protein Quantitation Begins with a New Generation of LC-MS

This GEN sponsored webinar focused on demonstrating the capabilities of the new generation Thermo Scientific™ Orbitrap™ Exploris™ mass spectrometry platforms and how they can be capitalized to address challenging analytical experiments in the domain of protein quantitation. Moreover, our presenters discussed the role of mass spectrometry in protein quantification with relation to anti-doping, infectious disease, and potential disease biomarker discovery.

Scientific Collaboration Using Innovative Remote Technologies

When COVID-19 started to spread across continents and become a global pandemic, biopharma manufacturers around the world faced two major challenges: (1) enter the race for treatment of the disease by participating in vaccine development and (2) avoid delays in the production of other essential therapeutics. This GEN webinar, sponsored by MilliporeSigma, presents two case studies from Europe and Latin America that demonstrate how the global teams across the M Lab™ Collaboration Center network used innovative remote technologies to overcome these challenges and meet important production timelines.

Multidimensional Approach to Decoding the Mysteries of Animal Development

In this GEN webinar, sponsored by GenScript, we explore the role of enhancer architecture on gene expression by creating synthetic networks for pattern formation.

Get Your CAR T-Cell Therapy Manufacturing Under Control

In this GEN webinar, sponsored by Sartorius, we will learn more about online monitoring for process control during the successful expansion of CAR T-cells.

A CRISPR Approach to Genetic Medicine

On Episode 6 of GEN Live, sponsored by Synthego, we’ll discuss with a pair of talented genome editing pioneers how CRISPR and allied technologies are showing promise for the treatment and diagnosis of genetic diseases and providing new clues to combat the COVID-19 pandemic.
Scroll Up